Document Detail


Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.
MedLine Citation:
PMID:  17302528     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Preterm birth (PTB) is the main cause of neonatal mortality and morbidity in the developed world. Historically, the approach for the prevention of PTB has been reactive rather than proactive. With the introduction of new screening tests and a greater emphasis on prevention rather than treatment, a number of new approaches have been introduced that show promise. Progesterone, which is responsible for myometrial quiescence in pregnancy and is used in women with a previous history of PTB, is associated with a significant reduction in the incidence of PTB and low birth weight. Infection is an important cause of PTB in < or = 40% of women. The appropriate antibiotics administered early in pregnancy to women with abnormal genital tract flora have been associated with a 40-60% reduction in the incidence of PTB. Although there has been debate regarding the benefits of nutritional supplementation for the prevention of many complications of pregnancy, recent evidence suggests that fish oil supplementation can be shown to reduce the incidence of PTB in women at risk of PTB. Although these three proactive, preventative approaches show promise, further research is needed to establish the best agent, the optimum gestational age at commencement and cessation, the ideal candidate patient to achieve a response and the long-term feto-maternal benefits and/or side effects.
Authors:
Ronald F Lamont; Anilla N Jaggat
Related Documents :
12908018 - Do maternal characteristics and past pregnancy experiences predict preterm delivery amo...
20629488 - Two-stage transvaginal cervical length screening for preterm birth in twin pregnancies.
19670048 - A subset of patients destined to develop spontaneous preterm labor has an abnormal angi...
1834048 - The short-term outcome of infants of multiple pregnancies delivered before 28 weeks' ge...
15301288 - Twin-twin transfusion syndrome: a review of treatment option.
16255738 - Jordanian women: perceptions and practices of first-time pregnancy.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on investigational drugs     Volume:  16     ISSN:  1744-7658     ISO Abbreviation:  Expert Opin Investig Drugs     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-02-16     Completed Date:  2007-04-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9434197     Medline TA:  Expert Opin Investig Drugs     Country:  England    
Other Details:
Languages:  eng     Pagination:  337-45     Citation Subset:  IM    
Affiliation:
Northwick Park & St Mark's NHS Trust, Department of Obstetrics & Gynaecology, Watford Road, Harrow, Middlesex, London, HA1 3UJ, UK. pauline.mills@nwlh.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Bacterial Agents / therapeutic use
Bacterial Infections / prevention & control
Dietary Supplements
Female
Humans
Nutritional Status
Obstetric Labor, Premature / prevention & control*
Pregnancy
Premature Birth / prevention & control*
Progesterone / therapeutic use
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Investigational agents against platinum-resistant ovarian cancer.
Next Document:  Telavancin: a novel lipoglycopeptide for serious gram-positive infections.